- Home
- RXRX vs CGAU Comparison
RXRX vs CGAU Comparison
Compare RXRX & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RXRX | CGAU |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 3.9B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RXRX | CGAU |
|---|---|---|
| Price | $3.45 | $18.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.20 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 14.3M | 1.4M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.17% |
| EPS Growth | ★ 14.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $74,681,000.00 | N/A |
| Revenue This Year | $16.50 | $23.72 |
| Revenue Next Year | $66.44 | $13.78 |
| P/E Ratio | ★ N/A | $11.74 |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.98 | $5.41 |
| 52 Week High | $7.18 | $21.17 |
Technical Indicators
Market Signals| Indicator | RXRX | CGAU |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 51.25 |
| Support Level | $2.98 | $16.97 |
| Resistance Level | $5.12 | $20.49 |
| Average True Range (ATR) | 0.21 | 1.01 |
| MACD | 0.02 | -0.18 |
| Stochastic Oscillator | 20.89 | 36.21 |
Price Performance
Historical ComparisonAbout RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About CGAU Centerra Gold Inc.
Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.